found that the common analgesic, opioid, triggered breast cancer metastasis via oncogenic JAK1/2-STAT3 signaling to promote epithelial-mesenchymal transition, emphasizing the importance of selective and restricted opioid use (39). Here, JAK1 is linked to breast carcinoma.